About the Company
We do not have any company description for TNF Pharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on TNF Pharmaceuticals, Inc.
MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF ...
TNF Pharmaceuticals retains the registered trademark MYMD-1® for its lead drug program. The Company’s new Investors website address is ir.tnfpharma.com. About TNF Pharmaceuticals, Inc.
TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting ...
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (formerly known as MyMD Pharmaceuticals, Inc.), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing ...
TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug ...
TNF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health announce the application ...
Contrasting TNF Pharmaceuticals (TNFA) and Its Competitors
TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in ...
TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial ...
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (formerly known as MyMD Pharmaceuticals, Inc.), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing ...
TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha ...
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the ...
TNF Pharmaceuticals and Renova Health Report Positive Results in ...
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the ...
TNF Pharmaceuticals Inc. Research & Ratings | TNFA | Barron's
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel ...
TNF Pharmaceuticals Announces Positive Clinical Data Supporting ...
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the ...
TNF Pharmaceuticals (TNFA) & The Competition Head to Head Review
TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in ...
TNF Pharmaceuticals Inc. (TNFA) Stock Price Today - WSJ
View the latest TNF Pharmaceuticals Inc. (TNFA) stock price, news, historical charts, analyst ratings and financial information from WSJ.
TNF Pharmaceuticals Prepares to Advance Lead Clinical Program ... - Nasdaq
TNF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, and autoimmune and inflammatory conditions, today announced ...
Similar Companies
Loading the latest forecasts...